These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 35714631)

  • 1. Investing in late-stage clinical trials and manufacturing of product candidates for five major infectious diseases: a modelling study of the benefits and costs of investment in three middle-income countries.
    Schäferhoff M; Zimmerman A; Diab MM; Mao W; Chowdhary V; Gill D; Karanja R; Madikizela M; Ogbuoji O; Yamey G
    Lancet Glob Health; 2022 Jul; 10(7):e1045-e1052. PubMed ID: 35714631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of a fixed-dose combination pill for secondary prevention of cardiovascular disease in China, India, Mexico, Nigeria, and South Africa: a modelling study.
    Lin JK; Moran AE; Bibbins-Domingo K; Falase B; Pedroza Tobias A; Mandke CN; Kazi DS
    Lancet Glob Health; 2019 Oct; 7(10):e1346-e1358. PubMed ID: 31477544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investing in a global pooled-funding mechanism for late-stage clinical trials of poverty-related and neglected diseases: an economic evaluation.
    Zimmerman A; Diab MM; Schäferhoff M; McDade KK; Yamey G; Ogbuoji O
    BMJ Glob Health; 2023 May; 8(5):. PubMed ID: 37247874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global funding trends for malaria research in sub-Saharan Africa: a systematic analysis.
    Head MG; Goss S; Gelister Y; Alegana V; Brown RJ; Clarke SC; Fitchett JRA; Atun R; Scott JAG; Newell ML; Padmadas SS; Tatem AJ
    Lancet Glob Health; 2017 Aug; 5(8):e772-e781. PubMed ID: 28668230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investment case for primary health care in low- and middle-income countries: A case study of Kenya.
    Mwai D; Hussein S; Olago A; Kimani M; Njuguna D; Njiraini R; Wangia E; Olwanda E; Mwaura L; Rotich W
    PLoS One; 2023; 18(3):e0283156. PubMed ID: 36952482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guide posts for investment in primary health care and projected resource needs in 67 low-income and middle-income countries: a modelling study.
    Stenberg K; Hanssen O; Bertram M; Brindley C; Meshreky A; Barkley S; Tan-Torres Edejer T
    Lancet Glob Health; 2019 Nov; 7(11):e1500-e1510. PubMed ID: 31564629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models.
    Eaton JW; Menzies NA; Stover J; Cambiano V; Chindelevitch L; Cori A; Hontelez JA; Humair S; Kerr CC; Klein DJ; Mishra S; Mitchell KM; Nichols BE; Vickerman P; Bakker R; Bärnighausen T; Bershteyn A; Bloom DE; Boily MC; Chang ST; Cohen T; Dodd PJ; Fraser C; Gopalappa C; Lundgren J; Martin NK; Mikkelsen E; Mountain E; Pham QD; Pickles M; Phillips A; Platt L; Pretorius C; Prudden HJ; Salomon JA; van de Vijver DA; de Vlas SJ; Wagner BG; White RG; Wilson DP; Zhang L; Blandford J; Meyer-Rath G; Remme M; Revill P; Sangrujee N; Terris-Prestholt F; Doherty M; Shaffer N; Easterbrook PJ; Hirnschall G; Hallett TB
    Lancet Glob Health; 2014 Jan; 2(1):e23-34. PubMed ID: 25104632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of violence against women and girls: A cost-effectiveness study across 6 low- and middle-income countries.
    Ferrari G; Torres-Rueda S; Chirwa E; Gibbs A; Orangi S; Barasa E; Tawiah T; Dwommoh Prah RK; Hitimana R; Daviaud E; Kapapa E; Dunkle K; Heise L; Stern E; Chatterji S; Omondi B; Ogum Alangea D; Karmaliani R; Maqbool Ahmed Khuwaja H; Jewkes R; Watts C; Vassall A
    PLoS Med; 2022 Mar; 19(3):e1003827. PubMed ID: 35324910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness and resource implications of aggressive action on tuberculosis in China, India, and South Africa: a combined analysis of nine models.
    Menzies NA; Gomez GB; Bozzani F; Chatterjee S; Foster N; Baena IG; Laurence YV; Qiang S; Siroka A; Sweeney S; Verguet S; Arinaminpathy N; Azman AS; Bendavid E; Chang ST; Cohen T; Denholm JT; Dowdy DW; Eckhoff PA; Goldhaber-Fiebert JD; Handel A; Huynh GH; Lalli M; Lin HH; Mandal S; McBryde ES; Pandey S; Salomon JA; Suen SC; Sumner T; Trauer JM; Wagner BG; Whalen CC; Wu CY; Boccia D; Chadha VK; Charalambous S; Chin DP; Churchyard G; Daniels C; Dewan P; Ditiu L; Eaton JW; Grant AD; Hippner P; Hosseini M; Mametja D; Pretorius C; Pillay Y; Rade K; Sahu S; Wang L; Houben RMGJ; Kimerling ME; White RG; Vassall A
    Lancet Glob Health; 2016 Nov; 4(11):e816-e826. PubMed ID: 27720689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Projecting the long-term economic benefits of reducing Shigella-attributable linear growth faltering with a potential vaccine: a modelling study.
    Puett C; Anderson JD; Bagamian KH; Muhib F; Scheele S; Hausdorff WP; Pecenka C
    Lancet Glob Health; 2023 Jun; 11(6):e892-e902. PubMed ID: 37202024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Net benefit and cost-effectiveness of universal iron-containing multiple micronutrient powders for young children in 78 countries: a microsimulation study.
    Pasricha SR; Gheorghe A; Sakr-Ashour F; Arcot A; Neufeld L; Murray-Kolb LE; Suchdev PS; Bode M
    Lancet Glob Health; 2020 Aug; 8(8):e1071-e1080. PubMed ID: 32710863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of rotavirus vaccination in Kenya and Uganda.
    Sigei C; Odaga J; Mvundura M; Madrid Y; Clark AD; ;
    Vaccine; 2015 May; 33 Suppl 1():A109-18. PubMed ID: 25919149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Burden and changes in HIV/AIDS morbidity and mortality in Southern Africa Development Community Countries, 1990-2017.
    Gona PN; Gona CM; Ballout S; Rao SR; Kimokoti R; Mapoma CC; Mokdad AH
    BMC Public Health; 2020 Jun; 20(1):867. PubMed ID: 32503604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global costs, health benefits, and economic benefits of scaling up treatment and imaging modalities for survival of 11 cancers: a simulation-based analysis.
    Ward ZJ; Scott AM; Hricak H; Atun R
    Lancet Oncol; 2021 Mar; 22(3):341-350. PubMed ID: 33662286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Burden of disease in francophone Africa, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
    El Bcheraoui C; Mimche H; Miangotar Y; Krish VS; Ziegeweid F; Krohn KJ; Ekat MH; Nansseu JR; Dimbuene ZT; Olsen HE; Tine RCK; Odell CM; Troeger CE; Kassebaum NJ; Farag T; Hay SI; Mokdad AH
    Lancet Glob Health; 2020 Mar; 8(3):e341-e351. PubMed ID: 32087171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Building the foundations for sustainable development: a case for global investment in the capabilities of adolescents.
    Sheehan P; Sweeny K; Rasmussen B; Wils A; Friedman HS; Mahon J; Patton GC; Sawyer SM; Howard E; Symons J; Stenberg K; Chalasani S; Maharaj N; Reavley N; Shi H; Fridman M; Welsh A; Nsofor E; Laski L
    Lancet; 2017 Oct; 390(10104):1792-1806. PubMed ID: 28433259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of HIV prevention for high-risk groups at scale: an economic evaluation of the Avahan programme in south India.
    Vassall A; Pickles M; Chandrashekar S; Boily MC; Shetty G; Guinness L; Lowndes CM; Bradley J; Moses S; Alary M; ; Vickerman P
    Lancet Glob Health; 2014 Sep; 2(9):e531-e540. PubMed ID: 25304420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-country analysis of national mental health investment case studies in sub-Saharan Africa and Central, South and South-East Asia.
    Chisholm D; Lee YY; Baral PP; Bhagwat S; Dombrovskiy V; Grafton D; Kontsevaya A; Huque R; Kalani Okware K; Kulikov A; Marahatta K; Mavunganidze P; Omar N; Prasai D; Putoud N; Tsoyi E; Vergara J
    Front Health Serv; 2023; 3():1214885. PubMed ID: 37533704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The case for investment in eye health: systematic review and economic modelling analysis.
    Wong B; Singh K; Everett B; O'Brien KS; Ravilla T; Khanna RC; Chase H; Frick KD
    Bull World Health Organ; 2023 Dec; 101(12):786-799. PubMed ID: 38024247
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.